Estrogen imprinting: When your epigenetic memories come back to haunt you

Endocrinology

Volumn 149, Issue 12, 2008, Pages 5919-5921

  Prins, Gail S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTRADIOL; GENISTEIN;

ADENOCARCINOMA; BREAST CANCER; CLEAR CELL CARCINOMA; DNA FINGERPRINTING; DNA METHYLATION; DNA MODIFICATION; EARLY MENOPAUSE; ENDOMETRIUM CARCINOMA; EPIGENETICS; GENOME IMPRINTING; HUMAN; HYPOSPADIAS; IMMUNOPATHOLOGY; INFERTILITY; LOW DRUG DOSE; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PSYCHOSEXUAL DISORDER; SEX DIFFERENCE; SHORT SURVEY; SPONTANEOUS ABORTION; SUBFERTILITY; TESTIS CANCER; UTERUS MALFORMATION; UTERUS MYOMA; VAGINA CARCINOMA;

ANIMALS; DIETHYLSTILBESTROL; DNA METHYLATION; EPIGENESIS, GENETIC; ESTROGENS; FEMALE; GENE EXPRESSION; GENISTEIN; HMGN PROTEINS; HUMANS; PROMOTER REGIONS, GENETIC; UTERUS;

EID: 57349134428     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1266     Document Type: Short Survey

References (25)

1. Gorski RA 1985 Sexual dimorphisms of the brain. J Anim Sci 61(Suppl 3):38-61
2. Roy AK, Chatterjee B 1983 Sexual dimorphism in the liver. Annu Rev Physiol 45:37-50
3. Herbst AL, Ulfelder H, Poskanzer DC 1971 Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284:878-881
4. Edelman DA 1986 Urogenital tract changes in female offspring exposed to DES. In: DES/diethylstilbestrol: new perspectives. Boston: MTP Press; 69-80
5. Giusti RM, Iwamoto K, Hatch EE 1995 Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 122:778-788
6. Strohsnitter W, Noller KL, Hoover RN, Robboy SJ, Palmer JR, Titus-Ernstoff L, Kaufman R, Adam E, Herbst A L, Hatch EE 2001 Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst 93:545-551
7. Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, Hoover RN 2006 Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15:1509-1514
8. Hatch EE, Troisi R, Wise LA, Hyer M, Palmer JR, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Adam E, Noller KL, Herbst AL, Robboy SJ, Hartge P, Hoover RN 2006 Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol 164:682-688
9. Titus-Ernstoff L, Troisi R, Hatch EE, Wise LA, Palmer JR, Hyer M, Kaufman R, Adam E, Strohsnitter W, Noller KL, Herbst AL, Gibson-Chambers J, Hartge P, Hoover RN 2006 Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int J Epidemiol 35:862-868
10. Newbold RR, Padilla-Banks E, Jefferson WN 2006 Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 147(Suppl):S11-S17
11. Colborn T 1995 Environmental estrogens: health implications for humans and wildlife. Environ Health Perspect 103(Suppl 7):135-136
12. Timms BG, Howdeshell KL, Barton L, Bradley S, Richter CA, vom Saal FS 2005 Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 102:7014-7019
13. Jefferson WN, Padilla-Banks E, Newbold RR 2007 Disruption of the female reproductive system by the phytoestrogen genistein. Reprod Toxicol 23:308-316
14. Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L 2008 The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer 98:1485-1493
15. Li S, Washburn KA, Moore R, Uno T, Teng C, Newbold RR, McLachlan JA, Negishi M 1997 Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res 57:4356-4359
16. Li S, Hansman R, Newbold R, Davis B, McLachlan JA, Barrett JC 2003 Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 38:78-84
17. Crews D, McLachlan JA 2006 Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology 147(Suppl):S4-S10
18. Andres AC, Muellener DB, Ryffel GU 1984 Persistence, methylation and expression of vitellogenin gene memory. Nucleic Acids Res 12:2283-2302
19. Edinger RS, Mabo E, Evans MI 1997 Estrogen-dependent transcriptional activation and vitellogenin gene memory. Mol Endocrinol 11:1985-1993
20. Ho SM, Tang WY, Belmonte J, Prins GS 2006 Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66:5624-5632
21. Tang WY, Newbokd RR, Mardilovich K, Jefferson WN, Cheng RY, Medvedovic M, Ho SM 2008 Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 149:5922-5931
22. Newbold RR, Bullock BC, McLachlan JA 1990 Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 50:7677-7681
23. Knudson Jr AG 1971 Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
24. Sollars V, Lu X, Xiao L, Wang X, Garfinkel MD, Ruden DM 2003 Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nat Genet 33:70-74
25. Ruden DM, Xiao L, Garfinkel MD, Lu X 2005 Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstibesterol on uterine development and cancer. Hum Mol Genet 14:R149-R155